Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Chamoto

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
International Immunology|July 5, 2020
Immune metabolism in PD-1 blockade-based cancer immunotherapyAlok Kumar, Kenji Chamoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Synergistic Effect of Immune Checkpoint Blockade Inhibition Therapy by Modulating T Cell Metabolism]Moto Shimazaki, Kenji Chamoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2016
Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) in cancer therapyRyusuke Hatae, Kenji Chamoto
International Immunology|June 17, 2003
A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cellsMarimo Sato, Kenji Chamoto, Takashi Nishimura
International Journal of Clinical Oncology|January 5, 2020
Current issues and perspectives in PD-1 blockade cancer immunotherapyKenji Chamoto, Ryusuke Hatae, Tasuku Honjo
Frontiers in Immunology|June 9, 2015
Adoptive T Cell Therapy Targeting CD1 and MR1Tingxi Guo, Kenji Chamoto, Naoto Hirano
Journal for Immunotherapy of Cancer|December 2, 2025
Age-related immune states and PD-1 blockade: mechanisms and strategies for the elderlyTomonori Yaguchi, Kenji Chamoto, Tasuku Honjo
Current Topics in Microbiology and Immunology|September 21, 2017
Role of PD-1 in Immunity and DiseasesKenji Chamoto, Muna Al-Habsi, Tasuku Honjo
Journal of Biomedical Science|April 6, 2017
Cancer immunotherapies targeting the PD-1 signaling pathwayYoshiko Iwai, Junzo Hamanishi, Kenji Chamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
Critical role of the CD44<sup>low</sup>CD62L<sup>low</sup> CD8<sup>+</sup> T cell subset in restoring antitumor immunity in aged miceYuka Nakajima, Kenji Chamoto, Takuma Oura, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
International Immunology|July 5, 2020
Immune metabolism in PD-1 blockade-based cancer immunotherapyAlok Kumar, Kenji Chamoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 9, 2020
[Synergistic Effect of Immune Checkpoint Blockade Inhibition Therapy by Modulating T Cell Metabolism]Moto Shimazaki, Kenji Chamoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 1, 2016
Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) in cancer therapyRyusuke Hatae, Kenji Chamoto
International Immunology|June 17, 2003
A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cellsMarimo Sato, Kenji Chamoto, Takashi Nishimura
International Journal of Clinical Oncology|January 5, 2020
Current issues and perspectives in PD-1 blockade cancer immunotherapyKenji Chamoto, Ryusuke Hatae, Tasuku Honjo
Frontiers in Immunology|June 9, 2015
Adoptive T Cell Therapy Targeting CD1 and MR1Tingxi Guo, Kenji Chamoto, Naoto Hirano
Journal for Immunotherapy of Cancer|December 2, 2025
Age-related immune states and PD-1 blockade: mechanisms and strategies for the elderlyTomonori Yaguchi, Kenji Chamoto, Tasuku Honjo
Current Topics in Microbiology and Immunology|September 21, 2017
Role of PD-1 in Immunity and DiseasesKenji Chamoto, Muna Al-Habsi, Tasuku Honjo
Journal of Biomedical Science|April 6, 2017
Cancer immunotherapies targeting the PD-1 signaling pathwayYoshiko Iwai, Junzo Hamanishi, Kenji Chamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2021
Critical role of the CD44<sup>low</sup>CD62L<sup>low</sup> CD8<sup>+</sup> T cell subset in restoring antitumor immunity in aged miceYuka Nakajima, Kenji Chamoto, Takuma Oura, et al.
Pageof 11